UpCoin Media@UpCoinMedia · 10h
IMMP Stock Closes at $0.3808 In the Middle of Today's Range
Open: $0.3840 High: $0.3864 Low: $0.3731 Close: $0.3808 Why it matters: IMMP finished in the middle of today's range.
#MarketClose#PennyStock
IMMP
Immutep Limited
Immutep is a biotechnology company focused on the development of novel LAG-3 related immunotherapeutic products for the treatment of cancer and autoimmune diseases.
2026 Price Target
$7.08
Average analyst target
0 followers
Currency
Monetary values are shown in your selected currency.
Stock Movement
Profit Simulator
Thursday, August 27
Low
$0.3732
High
$0.3864
Cost of Shares
—
Simulated Profit
—
Simulated results compare the selected period's low and high and do not represent an actual trade. Fees, taxes, slippage, and the ability to execute at exact prices are not included.
Community-Reported Results
Reported Profit
$0
0 profit reports
Reported Loss
$0
0 loss reports
Net Reported
$0
0 total reports
Community Outlook
No community outlook yet.
Be the first to vote when a poll becomes available.
What does the community think? Vote on $IMMP
0Followers1Active Polls7Recent Posts$0Reported Net
Latest â–¾
Bullish
Low
UpCoin Media@UpCoinMedia · 15h
IMMP Stock Falls to New Session Low of $0.38
IMMP is trading lower today at $0.38 (-0.9%).
#MarketAlert
Bullish
UpCoin Media@UpCoinMedia · 16h
IMMP Stock Opens at $0.3940
IMMP opened today's regular trading session at $0.3940, compared with its previous close of $0.3800. Opening difference: +3.7% Why it matters: The stock began trading 3.7% above its previous close.
#MarketOpen#PennyStocks
UpCoin Media@UpCoinMedia · 1d
IMMP Stock Sees Minor Decline During Trading Session
Immutep (IMMP) shares experienced a slight downward movement during today's trading session, closing at $0.38. The stock saw a modest decrease of approximately 1.1% as it traded within a narrow range. There were no major company-specific announcements or unusual volume spikes reported during the session to drive significant volatility. Price: $0.3800.
#IMMP#Biotech#Stocks
Bullish
UpCoin Media@UpCoinMedia · 1d
IMMP Is 295% Below Its Current Analyst Price Target
Current/closing price: $0.38 Average analyst price target: $1.50 Distance to target: +$1.12 / +294.7% Average recent daily movement: 5.7% At its recent average daily movement, the gap to the target represents a much larger move than the stock typically makes in a single session.
#PriceTarget#Research
UpCoin Media@UpCoinMedia · 1d
Immutep (IMMP) Faces Ongoing Securities Class Action Lawsuit
There have been no new material SEC filings from Immutep (IMMP) in the last few days. The company remains the subject of a securities class action lawsuit following the discontinuation of its TACTI-004 Phase III clinical trial in March 2026. Investors are currently being reminded of a July 6, 2026, deadline to serve as a lead plaintiff in the ongoing litigation regarding the company's previous risk disclosures. Price: $0.3861. Why it matters: The company is navigating legal challenges related to past clinical trial results and disclosure practices, which continues to be a point of focus for shareholders.
#IMMP#Biotech#Investing
Poll
Community poll
What Is Your Outlook for IMMP Stock This Week?
0 votes
Community sentiment and reported results reflect voluntary member input and should not be interpreted as investment advice or verified performance.